The stock quoted a 52-week high price of Rs 1063.75 and a low of Rs 660.1. The return on equity for the stock stood at 24.32 per cent. About 54,229 shares have changed hands on the counter so far.
The stock’s beta value, which measures its volatility in relation to the broader market, stood at 1.06.
The scrip has been an underperformer, down 12.58 per cent in the past one year in comparison with a 54.14 per cent gain in Sensex.
Technicals
On the technical charts, the 200-day moving average (DMA) of the stock stood at Rs 660.1 on October 07, while the 50-DMA was at Rs 767.94. If a stock trades well above 50-DMA and 200-DMA, it usually means the immediate trend is upward. On the other hand, if the stock trades well below 50-DMA and 200-DMA both, it is considered a bearish trend and if trades between these averages, then it suggests the stock can go either way.
Promoter/FII Holding
Promoters held 48.76 per cent stake in Aurobindo Pharma Ltd. as of 30-Jun-2021. Mutual funds and foreign institutional investors held 9.03 per cent and 23.7 per cent stake.
